It could be a bug bite. Or a harmless fatty lump. But it might be a mast cell tumor. In this episode of the VetFolio Voice podcast, we delve into mast cell tumors in dogs, including the unpredictable nature of these tumors, nuances around interpretation of cytology and histopathology reports, cytologic grading accuracy, and options for therapy including surgery, chemo, radiation and Stelfonta, an injectable mast cell tumor treatment for dogs. You’ll learn about staging considerations and the role of newer prognostic panels as well as strategies for client communication about mast cell disease.
All content for VetFolio Voice is the property of Powered by the NAVC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
It could be a bug bite. Or a harmless fatty lump. But it might be a mast cell tumor. In this episode of the VetFolio Voice podcast, we delve into mast cell tumors in dogs, including the unpredictable nature of these tumors, nuances around interpretation of cytology and histopathology reports, cytologic grading accuracy, and options for therapy including surgery, chemo, radiation and Stelfonta, an injectable mast cell tumor treatment for dogs. You’ll learn about staging considerations and the role of newer prognostic panels as well as strategies for client communication about mast cell disease.
The Pancreatitis Puzzle: Where Does Panoquell-CA1 Fit?
VetFolio Voice
37 minutes 28 seconds
3 months ago
The Pancreatitis Puzzle: Where Does Panoquell-CA1 Fit?
Canine pancreatitis remains a clinical challenge due to its varied presentation, complex pathophysiology, and potential for rapid deterioration. In this episode, we explore diagnostic strategies—including imaging and biomarker-based approaches—and review the foundational treatments of fluid therapy, analgesia, antiemetics, and nutritional support. We also highlight emerging therapies, with a focus on Panoquell-CA1 (fuzapladib sodium for injection), the first FDA conditionally approved drug designed to target inflammation in dogs with acute pancreatitis. Tune in as we unpack the science, share clinical insights, and discuss how this novel treatment may enhance multimodal care for this serious condition.
VetFolio Voice
It could be a bug bite. Or a harmless fatty lump. But it might be a mast cell tumor. In this episode of the VetFolio Voice podcast, we delve into mast cell tumors in dogs, including the unpredictable nature of these tumors, nuances around interpretation of cytology and histopathology reports, cytologic grading accuracy, and options for therapy including surgery, chemo, radiation and Stelfonta, an injectable mast cell tumor treatment for dogs. You’ll learn about staging considerations and the role of newer prognostic panels as well as strategies for client communication about mast cell disease.
